Zydus Lifesciences Partners Prolific Machines for Biologics Manufacturing

Zylidac Bio, a CDMO within the Zydus Lifesciences group, has partnered with Prolific Machines to scale Prolific's next-generation biologics manufacturing platform. This collaboration aims to transition Prolific's light-controlled cell line development technology from laboratory scale to Good Manufacturing Practice (GMP) production. The partnership will leverage Zylidac's Emeryville facility to scale Prolific's platform, which uses light to control protein expression, offering higher yields and improved quality for complex biologics. The initial phase involves tech transfer to a 50-liter scale,

This is a short summary. The full story is published by Stockwatch.